Results 81 to 90 of about 3,454 (161)

Pathogenetic Rationale for the Selection of Mucolytics with Multidirectional Action in the Treatment of Respiratory Diseases in Children

Zdorovʹe Rebenka, 2015
Violations of mucociliary clearance accompany any damage of the respiratory system. The paper presents the pathogenetic mechanisms of changes developing at this time and their consequences.
O.Ye. Chernyshova
doaj   +1 more source

The negative effects of mucolytics in otitis media with effusion

, 1987
CITATION: Van der Merwe, J. & Wagenfeld, D. J. H. 1987. The negative effects of mucolytics in otitis media with effusion. South African Medical Journal, 72:625-626.The original publication is available at http://www.samj.org.zaMuch controversy still ...
Van der Merwe, J., Wagenfeld, D. J. H.
core  

Non-invasive treatment of an acute sinusitis after open maxillary sinus floor augmentation with simultaneous bone graft and implant placement. Case Report. [PDF]

, 2017
Currently, the maxillary sinus floor augmentation technique is one of the most common procedures used in implantology. Despite being a straightforward techn istula, epistaxis, perforation of the Schneiderian membrane and acute sinusitis.
Fernández, Erick, Erick Fernández
core   +1 more source

Safety and efficacy of mucolytics in paediatric age

, 2011
Following a signal from France, which showed an increase in the cases of bronchial obstruction and worsening respiratory disorders in children under 2 years of age treated with mucolytics, the Italian Drug Agency (AIFA) has revised the risk/benefit ...
Del Principe D., Rossi P., Rossi R., Santuccio C., Zuccotti G. V., Tartaglia L., Baiardi P., Manzoni P., Di Pietro P., Barbieri I., Trotta F., Marchetti F., Rocchi F., Napoleone E.   +13 more
core  

Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease. [PDF]

, 2019
BACKGROUND: Individuals with chronic bronchitis or chronic obstructive pulmonary disease (COPD) may suffer recurrent exacerbations with an increase in volume or purulence of sputum, or both.
Fortescue, R, Kavin Sathananthan, Rebecca Fortescue, Sathananthan, K, Phillippa Poole, Poole, P   +5 more
core   +1 more source

Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease

, 2010
Individuals with chronic bronchitis or chronic obstructive pulmonary disease (COPD) may suffer recurrent exacerbations with an increase in volume and/or purulence of sputum and any therapy that reduced the number of exacerbations would be useful.
Black, PN, Poole, Phillippa
core   +1 more source

Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease

, 2006
Individuals with chronic bronchitis or chronic obstructive pulmonary disease (COPD) may suffer recurrent exacerbations with an increase in volume and/or purulence of sputum.
Phillippa Poole, Peter N Black, Black, PN, Poole, PJ   +3 more
core   +1 more source

Czy i kiedy stosować leki mukolityczne u chorych na przewlekłą obturacyjna chorobę płuc?

, 2022
Establishing the chronic obstructive pulmonary disease (COPD) phenotype is an important part of diagnosis and treatment planning which allows appropriate drug selection and maximizing therapeutic effect.
Suchodolski, Rafał; Uniwersyteckie Centrum Kliniczne w Gdańsku, Dębinki 7, 80-952 Gdańsk, Poland, Kuziemski, Krzysztof; Katedra i Klinika Alergologii i Pulmonologii, Gdański Uniwersytet Medyczny, Palus, Damian Krystian; Katedra i Klinika Nadciśnienia Tętniczego i Diabetologii, Gdański Uniwersytet Medyczny, Gdańsk, Poland, Czernia, Piotr; Katedra i Klinika Alergologii i Pulmonologii, Gdański Uniwersytet Medyczny   +3 more
core  

Physiology and pathophysiology of mucus and mucolytic use in critically ill patients

Airway mucus is a highly specialised secretory fluid which functions as a physical and immunological barrier to pathogens whilst lubricating the airways and humifying atmospheric air.
Cusack, Rebecca, Kemp, Ivan, Talbot, Thomas, Johal, Jayant, Webb, Elizabeth, Roe, Thomas, Dushianthan, Ahilanandan, Grocott, Michael P.W., Saeed, Kordo, Terrington, Isis   +9 more
core   +1 more source

From Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines to current clinical practice : an overview of the pharmacological therapy of stable chronic obstructive pulmonary disorder

, 2006
Background: The Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines have been promulgated to improve the management of chronic obstructive pulmonary disorder (COPD).
ANTONELLI INCALZI R, RENGO F., PEDONE C, BELLIA, Vincenzo, CORSONELLO A, MASOTTI G, GRASSI V   +6 more
core   +1 more source